| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 28 |
| 1 | METHOTREXATE SODIUM | 24 |
| 2 | THIOTEPA | 21 |
| 3 | DEXAMETHASONE | 20 |
| 4 | DEXAMETHASONE 1.5 MG | 20 |
| 5 | FLUDARABINE PHOSPHATE | 20 |
| 6 | CYTARABINE | 19 |
| 7 | PONATINIB HYDROCHLORIDE | 18 |
| 8 | VINCRISTINE SULFATE | 17 |
| 9 | CYCLOPHOSPHAMIDE | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PONATINIB HYDROCHLORIDE | 18 | 0.0034 |
| 1 | THIOTEPA | 21 | 0.0022 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 1 | 0.0012 |
| 3 | BUSULFAN | 14 | 0.0009 |
| 4 | VINCRISTINE SULFATE | 17 | 0.0006 |
| 5 | FLUDARABINE PHOSPHATE | 20 | 0.0005 |
| 6 | MERCAPTOPURINE | 7 | 0.0004 |
| 7 | CYTARABINE | 19 | 0.0003 |
| 8 | LANADELUMAB-FLYO | 1 | 0.0003 |
| 9 | C1 ESTERASE INHIBITOR RECOMBINANT | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 3 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 4 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 5 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 6 | Alkylating Drug [EPC] | 23 | 0.0001 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 28 | 0.0001 |
| 8 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 9 | Alkaloid [EPC] | 2 | 0.0001 |